BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
![Foto de BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS](/img/grupo.png)
![Foto de Fremantle Hospital](/img/noimage_org.png)
Fremantle Hospital
Fremantle, AustraliaPublikationen in Zusammenarbeit mit Forschern von Fremantle Hospital (1)
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477